Chargement en cours...
Risk factors in multiple myeloma: is it time for a revision?
Although therapeutic strategies have been adapted to age and comorbidities for a long time, almost all multiple myeloma (MM) patients currently receive similar treatment, whatever their disease risk category. However, high-risk MM patients still constitute an unmet medical need and should benefit fr...
Enregistré dans:
| Publié dans: | Blood |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7808011/ https://ncbi.nlm.nih.gov/pubmed/33024991 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019004309 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|